Transcriptional control of chemokine receptors and naive T cell trafficking

趋化因子受体和幼稚 T 细胞运输的转录控制

• 批准号: 8298995
• 负责人: Eric Sebzda
• 金额: $ 43.67万
• 依托单位: VANDERBILT UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-07-01 至 2014-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8298995
• 关键词: Actins; Address; Adoptive Transfer; Affect; Animal Model; Antibodies; Antigen-Presenting Cells; Autoimmune Diseases; Autoimmune Process; Autoimmunity; Biological Process; Blood; Blood Circulation; Blood Vessels; Cell Communication; Cell Survival; Cell physiology; Cells; Cellular Immunity; Chemokine Receptor Gene; Clinical; Data; Defect; Disease; Drug or chemical Tissue Distribution; Event; Frequencies; Gene Expression; Gene Expression Regulation; Genes; Genetic Enhancer Element; Genetic Transcription; Goals; Homing; Immune; Immune response; Immunocompromised Host; Individual; Inflammatory; Integrins; Kruppel-like transcription factors; Label; Lymph; Lymphatic vessel; Lymphocyte; Lymphoid; Mediating; Migration Assay; Molecular; Myocarditis; Nature; Organ; Pattern; Peripheral; Play; Predisposition; Process; Reaction; Reagent; Recruitment Activity; Regulation; Relative (related person); Reporter; Research; Research Proposals; Role; Self Tolerance; Series; Signal Transduction; T-Cell Activation; T-Lymphocyte; Testing; Therapeutic; Thymus Gland; Tissues; Transcriptional Regulation; Viral; Virus; adaptive immunity; anergy; base; cell mediated immune response; cell motility; chemokine; chemokine receptor; disorder control; functional status; gene repression; human disease; in vivo; insight; knockout animal; lymph nodes; migration; novel; pathogen; polymerization; prevent; promoter; public health relevance; receptor; receptor expression; response; thymocyte; time use; trafficking; transcription factor

DESCRIPTION (provided by applicant): T cell trafficking is a fundamental component of adaptive immunity, both in terms of effectively clearing foreign pathogens as well as limiting autoimmunity. Naive T cell migration is limited to a series of peripheral secondary lymphoid organs interconnected via blood and lymphatic vessels whereas activated effector T cells can escape this circulatory loop and enter peripheral tissues. To achieve these distinct migration patterns, naive and effector T cells respond to diverse chemokine gradients via homeostatic and inflammatory chemokine receptors (CRs), respectively. T cells acquire inflammatory CRs during an immune response when naive T cells interact with activated antigen presenting cells, however, the T cell-intrinsic molecular mechanisms involved in this receptor regulation are currently unknown. In this regard, preliminary evidence indicates that the transcription factor, Kr¿ppel-like factor 2 (Klf2), may play a crucial role in controlling CR gene expression. Naive T cells lacking Klf2 express inflammatory CRs and acquire novel trafficking patterns, including naive T cell distribution in peripheral non-secondary lymphoid organs. In addition, a subset of naive T cells appear to downregulate homeostatic CRs. Therefore, we hypothesize that Klf2 regulates transcription of CR genes, which is necessary for maintaining naive T cells in a homeostatic circulatory pattern and restricting T cell-mediated immune responses. This central hypothesis will be addressed by achieving three independent goals: (Aim 1) identifying Klf2-dependent mechanisms that repress inflammatory CRs and induce homeostatic CR gene transcription; (Aim 2) assessing the functional status of these CRs using Klf2-deficient T cells and determining which CRs are responsible for aberrant naive Klf2-deficient T cell trafficking in vivo, and; (Aim 3) establishing how unrestrained naive T cell trafficking affects cellular immunity at the cell-intrinsic level (anergy versus intact T cell effector functions) as well as at a host level (immunocompromised host versus effective pathogen clearance versus autoimmunity). These studies should provide important information concerning CR gene regulation in naive T cells, the affect atypical CR expression has on T cell migration and the immunological consequences of naive T cell trafficking into peripheral tissues. This research has important implications both with regards to broad biological processes such as CR regulation as well as clinical conditions such as pathogen clearance and T cell-mediated diseases like autoimmune myocarditis. Public Health Relevance: T lymphocytes mediate immune responses, both desired (such as clearance of disease-causing viruses) and undesired (such as attacking self-tissues in autoimmune diseases). The goal of this project is to determine how T cells migrate to various tissues to carry out these diverse functions and find out what happens when this migration process malfunctions. This research has important implications both with regards to pathogen clearance and autoimmunity, with potential therapeutic applications.

描述（由申请人提供）：T细胞运输是适应性免疫的基本组成部分，无论是在有效清除外来病原体方面还是在限制自身免疫方面。幼稚T细胞的迁移仅限于通过血液和淋巴管相互连接的一系列外周次级淋巴器官，而激活的效应T细胞可以逃离这种循环回路并进入外周组织。为了实现这些不同的迁移模式，幼稚T细胞和效应T细胞分别通过稳态和炎症趋化因子受体（CRs）对不同的趋化因子梯度做出反应。当初始T细胞与活化的抗原提呈细胞相互作用时，T细胞在免疫反应中获得炎性CRs，然而，参与这种受体调节的T细胞内在分子机制目前尚不清楚。在这方面，初步证据表明转录因子Kr¿pel样因子2 （Klf2）可能在控制CR基因表达中起关键作用。缺乏Klf2的幼稚T细胞表达炎性CRs并获得新的运输模式，包括幼稚T细胞在外周非继发性淋巴器官中的分布。此外，一组初始T细胞似乎下调稳态CRs。因此，我们假设Klf2调节CR基因的转录，这对于维持初始T细胞处于稳态循环模式和限制T细胞介导的免疫反应是必要的。这一中心假设将通过实现三个独立的目标来解决：（目标1）确定klf2依赖的抑制炎症性CR和诱导稳态CR基因转录的机制；（目的2）利用klf2缺陷T细胞评估这些CRs的功能状态，并确定哪些CRs负责体内异常的幼稚klf2缺陷T细胞运输；（目标3）确定不受限制的幼稚T细胞运输如何在细胞内在水平（能量与完整T细胞效应功能）以及在宿主水平（免疫受损宿主与有效病原体清除与自身免疫）影响细胞免疫。这些研究将提供有关CR基因在幼稚T细胞中的调控、非典型CR表达对T细胞迁移的影响以及幼稚T细胞转运到外周组织的免疫学后果的重要信息。这项研究对广泛的生物学过程（如CR调节）以及临床条件（如病原体清除）和T细胞介导的疾病（如自身免疫性心肌炎）都具有重要意义。公共卫生相关性：T淋巴细胞介导免疫反应，包括需要的（如清除致病病毒）和不需要的（如在自身免疫性疾病中攻击自身组织）。这个项目的目标是确定T细胞如何迁移到各种组织来执行这些不同的功能，并找出当这种迁移过程出现故障时会发生什么。这项研究在病原体清除和自身免疫方面具有重要意义，具有潜在的治疗应用。